IONS(Ionis Pharmaceuticals, Inc.) · 财务报表

IONS(Ionis Pharmaceuticals, Inc.) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$810.46M$587.37M$787.65M$705.14M$943.71M
毛利润$799.61M$573.25M$778.51M$693.92M$927.80M
营业利润−$30.19M−$410.19M−$353.73M−$475.08M−$381.68M
净利润−$28.60M−$269.72M−$366.29M−$453.90M−$381.39M
经营现金流$30.80M−$274.37M−$307.51M−$500.95M−$268.58M
自由现金流$18.84M−$290.09M−$331.32M−$546.23M−$320.03M
摊薄每股收益$-0.20$-1.90$-2.56$-3.04$-2.38

Ionis Pharmaceuticals, Inc. IONS